Furniss, J <br/><br/>
Regulating the pharmaceutical industry. General public does not support value system inherent in cost effectiveness analyses.  [electronic resource] 

 -  BMJ (Clinical research ed.)  Jan 1998 
 - 226; author reply 228 p.  digital 
<br/><br/> Publication Type: Letter; Comment 
<br/><br/><label>ISSN: </label>0959-8138 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Cost-Benefit Analysis<br/>Drug Industry--economics<br/>Humans<br/>Public Opinion<br/>United Kingdom